The effect of the cryopreserved swine skin substrate on the immune response of rats with normal homeostasis

Authors

  • Yu. S. Pyatnytsky O.O. Bohomolets National Medical University, Ukraine
  • L. V. Iakovleva National University of Pharmacy, Ukraine
  • O. Yu. Koshova National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/cphj.14.1307

Keywords:

cryopreserved swine skin substrate, antibody-mediated immunity, cell-mediated immunity, anti-allergic properties

Abstract

The aim of this work was to determine the immunotropic properties of the cryopreserved swine skin substrate (CSSS) in animals with normal homeostasis. The study was conducted in male mice weighing 18.0-20.0 g and male rats weighing 180.0-200.0 g. The effect of prophylactic oral CSSS doses of 200 and 500 mg/kg on the phagocytic activity of neutrophils, the state of oxygen-dependent antimicrobial neutrophil systems was evaluated in the test of nitroblue tetrazolium reduction (NBT-test), the antibody response (the number of antibody-forming cells and the level of hemagglutinin and hemolysin in the serum) and development of the reaction of the delayed type hypersensitivity have been studied. A significant immune-modulating activity of CSSS has been found, the oppositely directed character of this activity when the drug is used in two doses of 200 mg/kg and 500 mg/kg has been determined. In low doses CSSS induces activation of the nonspecific link of the immunity and suppressive processes of the cell-mediated immune response. When it is used in high doses, the stimulation of serogenesis processes is observed. The results obtained justify feasibility and prospects of further study of the mechanisms of the CSSS action in order to create a highly effective anti allergic drug.

References

Абрамченко В.В. Фармакотерапия гестоза. – С.Пб.: СпецЛит, 2010. – 477 с.

Венцковский Б.М., Запорожан В.Н., Сенчук А.Я. и др. Гестозы: Руковод. для врачей. – М.: Мед. информ. агентство, 2005. – 312 с.

Вихляева Е.М. // Акушерство и гинекол. – 2009. – №2. – С. 5-7.

Яковлєва Л.В., Зайченко Г.В., Ципкун А.Г. та ін. Доклінічне вивчення лікарських засобів, призначених для лікування плацентарної дисфункції: Метод. рекоменд. – К. : ДФЦ МОЗ України, 2009. – 59 с.

Кустаров В.Н., Линде В.А. Гестоз: патогенез, симптоматика, лечение. – С.Пб.: Гиппократ, 2012. – 125 с.

Машковский М.Д. Лекарственные средства. – 17-е изд., перераб., испр. и доп. – М.: Новая волна: Издатель Умеренков, 2011. – 1216 с.

Оганов Р.Г., Небиеридзе Д.В. Метаболические и сосудистые эффекты антигипертензивной терапии. – М.: Универсум Паблишинг, 2010. – С. 126-131.

Bayliss H., Chuchill D., Beevers M. et al. // Hypertens. Pregnancy. – 2012. – Vol. 21, №1. – P. 161-174.

Bowen R.S., Moodley J., Dutton M.F. et al. // J. Obstet. Gynaecol. – 2011. – Vol. 21, №6. – P. 563-569.

Cunningham F.G., Lindheimer M.D. // New End. – 2012. – Vol. 326, №9. – Р. 927-932.

Irons D.W., Baylis P.H., Batler T.J. et al. // Amer. J. Physiol. – 2007. – Vol. 273, №3. – Р. 483-487.

Lain K.Y., Roberts M. // JAMA. – 2010. – Vol. 287, №24. – P. 3183-3186.

Magee L.A. // Drug Safety. – 2011. – Vol. 24, №6. – P. 457-474.

Peters R.M., Flack J.M. // J. Obstet. Gynecol. – 2012. – Vol. 33, №2. – P. 209-220.

Piepsz A., Tondeur M., Ham H. et al. // Eur. J. Nucl. Med. And Mol. Imag. – 2012. – Vol. 39, №3. – Р. 295.

Redman C.W., Sargent I.L. // Gynecol. Obstet. Fertil. – 2011. – Vol. 29, №7-8. – P. 518-522.

Downloads

Published

2014-06-10

Issue

Vol. 18 No. 2 (2014)

Section

Pre-clinical studies of new drugs

License

Copyright (c) 2014 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).